"Whether it’s a one-day stay for same day surgery or several weeks for rehabilitation, Sanford Bismarck Medical Center will serve you with the compassionate care you deserve."

During the past decade, Sanford Bismarck Medical Center conducted 179 clinical trials. In the 10-year time frame, 179 clinical trials started and 118 clinical trials were completed, i.e. on average, 65.9% percent of trials that started reached the finish line to date. In the past 5 years, 71 clinical trials started and 71 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanford Bismarck Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 133 trials, followed by "Alliance for Clinical Trials in Oncology" with 37 trials sponsored, "SWOG Cancer Research Network" with 35 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored and "NRG Oncology" with 20 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanford Bismarck Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 130 trials as a collaborator, "NRG Oncology" with 35 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Sanford Bismarck Medical Center" are "Recurrent Breast Carcinoma" (13 trials), "Stage IV Breast Cancer AJCC v6 and v7" (11 trials), "Stage IV Lung Cancer AJCC v8" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials) and "Invasive Breast Carcinoma" (9 trials). Many other conditions were trialed in "Sanford Bismarck Medical Center" in a lesser frequency.

Most popular intervention types in "Sanford Bismarck Medical Center" are "Drug" (212 trials), "Other" (173 trials), "Biological" (105 trials), "Procedure" (68 trials) and "Radiation" (61 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (90 trials), "Quality-of-Life Assessment" (76 trials), "Questionnaire Administration" (45 trials), "Paclitaxel" (37 trials) and "Carboplatin" (35 trials). Other intervention names were less common.

The vast majority of trials in "Sanford Bismarck Medical Center" are 209 trials for "All" genders, 52 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Sanford Bismarck Medical Center". undefined are not yet recruiting, 68 are recruiting, 120 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Sanford Bismarck Medical Center, 8 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Sanford Bismarck Medical Center, 12 "Phase 1" clinical trials were conducted, 112 "Phase 2" clinical trials and 161 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".